MOULTON SURGERY
120 NORTHAMPTON LANE NORTH, MOULTON, NORTHAMPTON
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 12 | 12 | 100.0% | |
| HF 4 | 2011 | 13 | 14 | 92.9% | |
| HF 4 | 2012 | 15 | 16 | 93.8% | |
| HF 4 | 2013 | 15 | 16 | 93.8% | |
| HF004 | 2014 | 10 | 10 | 100.0% | |
| HF004 | 2015 | 15 | 16 | 93.8% | |
| HF004 | 2016 | 15 | 15 | 100.0% | |
| HF004 | 2017 | 31 | 33 | 93.9% | |
| HF004 | 2018 | 37 | 40 | 92.5% | |
| HF004 | 2019 | 39 | 42 | 92.9% | |
| HF004 | 2020 | 36 | 38 | 94.7% | |
| HF006 | 2021 | 43 | 43 | 100.0% | |
| HF006 | 2022 | 38 | 39 | 97.4% | |
| HF006 | 2023 | 38 | 40 | 95.0% |
